Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06822569 · ClinicalTrials.gov registry record · NA

Teen Health Choices & Wellness

A NA study of Substance Use and Health Behavior, sponsored by Brown University.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT06822569: Recruiting NA study of Substance Use and Health Behavior, sponsored by Brown University.

NCT06822569 is a NA study of Substance Use and Health Behavior that is actively recruiting participants, run by Brown University. The registered enrollment target is 224 participants, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06822569, a NA study of Substance Use and Health Behavior, is actively recruiting participants, sponsored by Brown University.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn more about changes in health, wellness, and substance-use behaviors as teenagers get older. Participants, ages 13 to 16, will be asked to use a smartphone application developed for this research study. Participants will also come to Brown University or meet via video conference to answer questions about specific behaviors, choices, and feelings that may change over time.

Primary Outcome

This study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." The specific item to assess positive effects is the question, "How strong is your craving to use cannabis right now" sourced from the Morean' Drug Craving Questionnaire-Now. See reference section.

Interventions

  • OTHER Cue reactivity paradigm

Study Locations (1)

Rhode Island

  • Brown University School of Public Health - Providence

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2024-12-27
Est. Completion 2028-02
Phase NA
Brown University

231 total trials

What NCT06822569 shows while recruiting

NCT06822569 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (82% lower).

The record links to 3 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Cue reactivity paradigm is the first listed.

NCT06822569 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06822569 about?

NCT06822569 is a clinical study titled "Teen Health Choices & Wellness". The goal of this observational study is to learn more about changes in health, wellness, and substance-use behaviors as teenagers get older. Participants, ages 13 to 16, will be asked to use a smartphone application developed for this research study. Participants will also come to Brown University o...

What is the current status of trial NCT06822569?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2024-12-27. Estimated completion is 2028-02.

What conditions does trial NCT06822569 study?

This clinical trial studies the following conditions: Substance Use, Health Behavior, Wellness, Psychological.

What interventions are being tested in trial NCT06822569?

The interventions under investigation include: Cue reactivity paradigm (OTHER).

Who is sponsoring clinical trial NCT06822569?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06822569 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06822569's enrollment target sits among peer trials

224 45th of 88 higher than 44 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06822569, the US trial registry maintained by the National Library of Medicine. NCT06822569 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.